Human telomerase and its regulation

Microbiology and Molecular Biology Reviews

Volumn 66, Issue 3, 2002, Pages 407-425

  Cong, Yu Sheng ^a   Wright, Woodring E ^a   Shay, Jerry W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID HORMONE; TELOMERASE; ZINC FINGER PROTEIN;

ARTICLE; CELL PROLIFERATION; CELL SPECIFICITY; ENZYME ACTIVITY; ENZYME REGULATION; GENETIC ORGANIZATION; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN ASSEMBLY; PROTEIN LOCALIZATION; PROTEIN PROCESSING; TELOMERE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; NEOPLASMS; ONCOGENE PROTEINS, VIRAL; PROMOTER REGIONS (GENETICS); PROTEIN PROCESSING, POST-TRANSLATIONAL; REFERENCE VALUES; REPRESSOR PROTEINS; SP1 TRANSCRIPTION FACTOR; STEROIDS; TELOMERASE; TELOMERE; TRANSCRIPTION, GENETIC;

EUKARYOTA;

EID: 0036712072     PISSN: 10922172     EISSN: None     Source Type: Journal    
DOI: 10.1128/MMBR.66.3.407-425.2002     Document Type: Article

References (273)

1. Telomerase regulation: Not just flipping the switch
2. Effects of tamoxifen on telomerase activity in breast carcinoma cell lines
3. Targeting assay to study the cis functions of human telomeric proteins: Evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2
4. N-terminal domains of the human telomerase catalytic sub-unit required for enzyme activity in vivo
5. Mice without telomerase: What can they teach us about human cancer?
6. p53-induced apoptosis as a safeguard against cancer
7. Recruitment of p300/CBP in p53-dependent signal pathways
8. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues
9. Histone deacetylases: Transcriptional repression with SINers and NuRDs
10. Functional reconstitution of human telomerase expressed in Saccharomyces cerevisiae
11. Human telomerase RNA-protein interactions
12. Microcell-mediated transfer of chromosome 4 into HeLa cells suppresses telomerase activity
13. Potl, the putative telomere end-binding protein in fission yeast and humans
14. Telomere position effect in human cells
15. Functional multimerization of the human telomerase reverse transcriptase
16. Polymerization defects within human telomerase are distinct from telomerase RNA and TEP1 binding
17. Reconstitution of human telomerase activity in vitro
18. CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia
19. Telomerase activity: A biomarker of cell proliferation, not malignant transformation
20. Reprogramming of telomerase activity and rebuilding of telomere length in cloned cattle
21. Switching and signaling at the telomere
22. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA
23. Mechanism of telomerase induction during T cell activation
24. Extension of life-span by introduction of telomerase into normal human cells
25. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism
26. Telomerase reverse transcriptase genes identified in Tetrahymena thermophila and Oxytricha trifallax
27. Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15.33 by fluorescence in situ hybridization
28. Telomerase regulation during entry into the cell cycle in normal human T cells
29. CpG methylation as a mechanism for the regulation of E2F activity
30. Secondary structure of vertebrate telomerase RNA
31. Differential inhibition of telomerase activity during induction of differentiation in hematopoietic, melanoma, and glioma cells in culture
32. The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity
33. Ciliate telomerase biochemistry
34. The reverse transcriptase component of the Tetrahymena telomerase ribonucleoprotein complex
35. Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme
36. Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells
37. The human telomerase catalytic subunit hTERT: Organization of the gene and characterization of the promoter
38. Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres
39. Telomere shorthening associted with chromosome instability is arrested in immortal cells which express telomerase activity
40. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization
41. The catalytic subunit of yeast telomerase
42. Histone deacetylases, transcriptional control, and cancer
43. Rb and E2F-1 regulate telomerase activity in human cancer cells
44. Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells
45. Control of histone modifications
46. Protection of mammalian telomeres
47. Structure and variability of human chromosome ends
48. myc family oncogenes in the development of normal and neoplastic cells
49. Methylation of the human telomerase gene CpG island
50. DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene
51. Stable expression in yeast of the mature form of human telomerase RNA depends on its association with the box H/ACA small nucleolar ribonucleoprotein proteins Cbf5p, Nhp2p and Nop10p
52. Inactivation of 14-3-3 sigma influences telomere behavior and ionizing radiotion-induced chromosomal instability
53. Histone deacetylase I can repress transcription by binding to Sp1
54. Dyskeratosis congenita. A disease of premature ageing
55. In vitro assembly of human H/ACA small nucleolar ribonucleoproteins reveals unique features of U17. and telomerase RNAs
56. Telomerase and retrotransposons: Which came first?
57. Regulation of p53 downstream genes
58. Species-specific interaction of the glutamine-rich activation domains of Sp1 with the TATA box-binding protein
59. Identification of human tumour suppressor genes by monochromosome transfer: Rapid growth-arrest response mapped to 9p21 is mediated solely by the cyctin-D-dependent kinase inhibitor gene, CDKN2A (p16INK4A)
60. WT1-more than a transcription factor?
61. The nucleolar localization domain of the catalytic subunit of human telomerase
62. Estl and Cdc13 as comediators of telomerase access
63. Positive and negative regulation of telomerase access to the telomere
64. The RNA component of human telomerase
65. hnRNP A1 may interact simultaneously with telomeric DNA and the human telomerase RNA in vitro
66. Disruption of the telomerase catalytic subunit gene from Arabidopsis inactivates telomerase and leads to a slow loss of telomeric DNA
67. The La antigen associates with the human telomerase ribonucleoprotein and influences telomere length in vivo
68. Heterogeneous nuclear ribonucleoproteins C1 and C2 associate with the RNA component of human telomerase
69. Cdc25B activity is regulated by 14-3-3
70. Stable association of hsp90 and p23, but Not hsp70, with active human telomerase
71. Essential functions of amino- terminal domains in the yeast telomerase catalytic subunit revealed by selection for viable mutants
72. Identification and characterization of negative regulatory elements of the human telomerase catalytic subunit (hTERT) gene promoter: Possible role of MZF-2 in transcriptional repression of hTERT
73. Adenovirus-mediated overexpression of p151NK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A
74. Human papillomavirus type 16 E6-induced degradation of E6TPI correlates with its ability to immortalize human mammary epithelial cells
75. E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc
76. Replicative senescence: The human fibroblast comes of age
77. The Myc/Max/Mad network and the transcriptional control of cell behavior
78. Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation
79. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation
80. Telomerase activity, cell proliferation, and cancer
81. Telomeres do D-loop-T-loop
82. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts
83. TRF1. Promotes parallel pairing of telomeric tracts in vitro
84. Mammalian telomeres end in a large duplex loop
85. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity
86. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers
87. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1
88. Cloning and expression of hamster telomerase catalytic subunit cDNA
89. Creation of human tumour cells with defined genetic elements
90. Inhibition of telomerase limits the growth of human cancer cells
91. Induction of telomerase activity by UV-irradiation in Chinese hamster cells
92. Cooperative effect of antisense-RB and antisense-p53 in the regulation of cellular senescence
93. Chromatin remodeling and Rb activity
94. Telomerase is not an oncogene
95. Telomeres shorten during ageing of human fibroblasts
96. The telomere hypothesis of cellular aging
97. A mammalian telomerase-associated protein
98. Human telomerase contains evolutionarily conserved catalytic and structural subunits
99. Telomere reduction in human colorectal carcinoma and with ageing
100. The limited in vitro lifetime of human diploid cell strains
101. Hormonal chemoprevention of cancer in women
102. Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16 and E2F1 genes by means of recombinant adenovirus
103. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death
104. 5,6-Trans-16-ene-vitamin D3: A new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells
105. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells
106. Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators
107. Database of p53 gene somatic mutations in human tumors and cell lines
108. Functional requirement of p23 and Hsp90 in telomerase complexes
109. Lack of cell cycle regulation of telomerase activity in human cells
110. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene
111. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells
112. Telomerase activity in hybrids between telomerase-negative and telomerase-positive immortal human cells is repressed in the different complementation groups but not in the same complementation group of immortality
113. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype
114. The role of DNA methylation in mammalian epigenetics
115. Adenoviral expression of p53 represses telomerase activity through downregulation of human telomerase reverse transcriptase transcription
116. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit
117. p53-and ATM-dependent apoptosis induced by telomeres lacking TRF2
118. Senescence induced by altered telomere state, not telomere loss
119. Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase
120. Functional interaction between DNA-PK and c-Abl in response to DNA damage
121. Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone
122. Vaults and telomerase share a common subunit, TEP1
123. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types
124. Specific association of human telomerase activity with immortal cells and cancer
125. TIN2, a new regulator of telomere length in human cells
126. Telomerase activation by the E6 gene product of human papillomavirus type 16
127. p53: Puzzle and paradigm
128. A novel telomerase-specific gene therapy: Gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter
129. RNA location and modeling of a WD40 repeat domain within the vault
130. Telomerase activity is down regulated via decreases in hTERT mRNA but not TEP1 mRNA or hTERC during the differentiation of leukemic cells
131. Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture
132. Adenovirus-mediated p53 gene trans-duction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells
133. Estrogen activates telomerase
134. Telomerase activity in human endometrium
135. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT)
136. Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase
137. DNA methylation and cancer
138. Extension of cell life-span and telomere length in animals cloned from senescent somatic cells
139. PKB/Akt: A key mediator of cell proliferation, survival and insulin responses?
140. Identification of two RNA-binding proteins associated with human telomerase RNA
141. Essential role of mouse telomerase in highly proliferative organs
142. The human telomerase gene: Complete genomic sequence and analysis of tandem repeat polymorphisms in intronic regions
143. Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes
144. p53, the cellular gatekeeper for growth and division
145. Telomerase is controlled by protein kinase Calpha in human breast cancer cells
146. Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells
147. In vivo loss of telomeric repeats with age in humans
148. Purification of telomerase from Euplotes aediculatus: Requirement of a primer 3′ overhang
149. Reverse transcriptase motifs in the catalytic subunit of telomerase
150. Protein kinase C and its substrates
151. Cutting edge: Telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation
152. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes
153. Telomerase-associated protein TEP1 is not essential for telomerase activity or telomere length maintenance in vivo
154. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters
155. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening
156. Putative telomerase catalytic subunits from Giardia lamblia and Caenorhabditis elegans
157. Human genetics. Testing telomerase
158. Tetrahymena proteins p8O and p95 are not core telomerase components
159. The terminal DNA structure of mammalian chromosomes
160. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc
161. New function of CDC13 in positive telomere length regulation
162. Two telomerase reverse transcriptases (TERTs) expressed in Candida albicans
163. hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization
164. The Tetrahymena p80/p95 complex is required for proper telomere length maintenance and micronuclear genome stability
165. Hypoxia extends the life span of vascular smooth muscle cells through telomerase activation
166. Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells
167. A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3′ end
168. Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase
169. A telomerase component is defective in the human disease dyskeratosis congenita
170. hTR repressor-related gene on human chromosome 10p15.1
171. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase
172. Functional multimerization of human telomerase requires an RNA interaction domain in the N terminus of the catalytic subunit
173. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a
174. 14-3-3 Proteins: Regulation of subcellular localization by molecular interference
175. Introduction of chromosome 7 suppresses telomerase with shortening of telomeres in a human mesothelial cell line
176. Reversing time: Origin of telomerase
177. Telomerase catalytic subunit homologs from fission yeast and human
178. TLP1: A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family
179. Tamoxifen and gonadal steroids inhibit colon cancer growth in association with inhibition of thymidylate synthase, survivin and telomerase expression through estrogen receptor beta mediated system
180. Intact functional domains of the retinoblastoma gene product (pRb) are required for downregulation of telomerase activity
181. Rb targets histone H3 methylation and HP1 to promoters
182. Functional evidence for a telomerase repressor gene on human chromosome 10p15.1
183. Molecular cloning and characterization of AtTERT, a telomerase reverse transcriptase homolog in Arabidopsis thaliana
184. The Wilms' tumor I tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene
185. In vivo and in vitro analyses of Myc for differential promoter activities of the human telomerase (hTERT) gene in normal and tumor cells
186. Identification of Mad as a repressor of the human telomerase (hTERT) gene
187. Telomerase activation by human papillomavirus type 16 E6 protein: Induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites
188. The nucleolus: An old factory with unexpected capabilities
189. Multiple pathways to cellular senescence: Role of telomerase repressors
190. Telomerase activity does not always imply telomere maintenance
191. Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase
192. ATM function and telomere stability
193. Mitotic and G2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216
194. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons
195. Human H/ACA small nucleolar ribonucleoproteins and telomerase share evolutionarily conserved proteins NHP2 and NOP10
196. Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT)
197. Transcription from a TATA-less promoter requires a multisubunit TFIID complex
198. Regulation of telomerase during human placental differentiation: A role for TGFbetal
199. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions
200. The papillomavirus E6 proteins
201. CpG methylation, chromatin structure and gene silencing-a three-way connection
202. DNA methylation and mammalian epigenetics
203. Nuclear cloning and epigenetic reprogramming of the genome
204. Expression of the human telomerase reverse transcriptase is not related to telomerase activity in normal and malignant renal tissue
205. Senescence as a mode of tumor suppression
206. Involvement of 14-3-3 proteins in nuclear localization of telomerase
207. Saccharomyces cerevisiae telomerase is an Sm small nuclear ribonucleoprotein particle
208. Differentiation of immortal cells inhibits telomerase activity
209. Toward identifying a cellular determinant of telomerase repression
210. A survey of telomerase activity in human cancer
211. A role for both RB and p53 in the regulation of the cellular senescence
212. Hayflick, his limit, and cellular ageing
213. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts
214. Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 larger T-antigen
215. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres
216. Control of human telomere length by TRF1 and TRF2
217. TRF1 inhibits telomere C-strand DNA synthesis in vitro
218. Effects of androgens on telomerase activity in normal and malignant prostate cells in vitro
219. Telomerase suppression by chromosome 6 in a human papillomavirus type 16-immortalized keratinocyte cell line and in a cervical cancer cell line
220. Transient expression of human telomerase extends the life span of normal human fibroblasts
221. BRG-1 is required for RB-mediated cell cycle arrest
222. The Sp-family of transcription factors
223. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and nontumor tissue sections
224. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells
225. Telomerase activation by histone deacetylase inhibitor in normal cells
226. Evidence for a putative telomerase repressor gene in the 3p14.2-p21.1 region
227. Expression of telomerase activity in human endometrium is localized to epithelial glandular cells and regulated in a menstrual phase-dependent manner correlated with cell proliferation
228. Two inactive fragments of the integral RNA cooperate to assemble active telomerase with the human protein catalytic subunit (hTERT) in vitro
229. Transcriptional silencing at Saccharomyces telomeres: Implications for other organisms
230. Formation of functional tissue from transplanted adrenocortical cells expressing telomerase reverse transcriptase
231. RB and hbrm cooperate to repress the activation functions of E2F1
232. Identification of a novel transcription factor binding element involved in the regulation by differentiation of the human telomerase (hTERT) promoter
233. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts
234. Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development
235. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium
236. Control of telomere length by the human telomeric protein TRF1
237. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
238. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein
239. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
240. De novo telomere addition by Tetrahymena telomerase in vitro
241. Myc activates telomerase
242. Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway
243. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT
244. Reconstitution of wild-type or mutant telomerase activity in telomerase-negative immortal human cells
245. Human telomerase contains two cooperating telomerase RNA molecules
246. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT)
247. Experimental elongation of telomeres extends the lifespan of immortal X normal cell hybrids
248. Reversible cellular senescence: Implications for immortalization of normal human diploid fibroblasts
249. Telomerase activity in human germline and embryonic tissues and cells
250. Cellular senescence as a tumor protection mechanism: The essential role of counting
251. Telomere positional effects and the regulation of cellular senescence
252. The two-stage mechanism controlling cellular senescence and immortalization
253. Normal human chromosomes have long G-rich telomeric overhangs at one end
254. NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres
255. Direct activation of TERT transcription by c-MYC
256. Identification of functionally important domains in the N-terminal region of telomerase reverse transcriptase
257. Interferon alpha downregulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cells
258. Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: Regulatory mechanisms
259. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells
260. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells
261. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition
262. Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells
263. Human endothelial cell life extension by telomerase expression
264. Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels
265. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity
266. Alternatively spliced variant deleting exons 7 and 8 of the human telomerase reverse transcriptase gene is dominantly expressed in the uterus
267. Telomerase is regulated by protein kinase C-zeta in human nasopharyngeal cancer cells
268. Frequent amplification of the telomerase reverse transcriptase gene in human tumors
269. Rb-mediated chromatin structure regulation and transcriptional repression
270. Telomerase activity in human acute myelogenous leukemia: Inhibition of telomerase activity by differentiation-inducing agents
271. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells
272. The retinoblastoma gene: A prototypic and multifunctional tumor suppressor
273. The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor